Member Info for Uncanny

See RNS….too much to summarise.

Fiuther big developments for Inaphea:

Revenue, Swiss and NHS tie up, now Ovarian Cancer plus top 10 prioritised candidate :

“We will be developing a data package for these assets based on PDC profiling, initially in Ovarian cancer, and our new in-silico clinical prediction and precision biomarker approach for patient selection with TwinEdge providing a virtual clinical trial data set to take forward into partnering discussions whilst actively applying for grant funding to continue their development. We're also working with Dominion to support outreach and promotion of the PredictRx platform with early revenue anticipated as soon as Q4 2025."“

Why will he hand his Notice in Terminating his employment?

CLX, IMHO is a 9 figure total deal sum for VAL to secure in early partnering now pretty much IND ready I presume.

DYOR, NAI, GLA

“ValiRx CEO and Cytolytix Director, Mark Eccleston, will be presenting Cytolytix oncolytic peptide program at the Charles River Biotech Symposium in Carlsbad (7 - 10 September 2025) and at the Oxford Global Discovery & Development US 2025 in San Diego (2 - 3 October 2025) following a series of presentations earlier in the year. These meetings represent excellent partnering opportunities as exemplified by the deal with Omios Bio which followed IO 360 in Boston in January 2025. ValiRx is in discussions with several potential partners to progress Cytolytix, including a major pharmaceutical company and further non-dilutive funding options with our academic partners. “

Season 2 of ValiRx the comeback has just dropped kn Spotify

https://open.spotify.com/show/6KyFC22iB2BaS1mMSKckWE

I have a sneaky feeling we’ll creep up to warrant price now over the weeks or should a big RNS land, quite instantly!

GLA DYOR NAI

Just done a dummy trade out of curiosity and doesn't look like there is much stock around and paying a premium for selling.... bodes well as the news continues to flow in from ME.

GLA NAI DYOR

Quite bizarre and another 2 x 2 just gone through this hour....?

Some good posts their Patern!

If you weren’t so sarcastic and read the detail you will see the comparisons.

The first is AZN in 2025 and the second is an illustration of the potential deal sizes for breast (CLX) , lung and pancreatic (401) and prostate cancer (201 / CLX) of which 3 are with AZN.

Https://www.fiercebiotech.com/special-report/top-15-biopharma-licensing-deals-2020

Examples:

https://www.theguardian.com/business/2025/mar/17/astrazeneca-biotech-cancer-cell-therapy-esobiotec-imfinzi

https://www.theguardian.com/business/2025/mar/17/astrazeneca-biotech-cancer-cell-therapy-esobiotec-imfinzi

Https://www.linkedin.com/posts/mark-eccleston-48382a_smallcap-activity-7368610371445628928-ogJ2?utm_source=share&utm_medium=member_ios&rcm=ACoAAA1LIgwBr8suZ6-q_42u9B82OT6Z-mDlizk

Jinky, we only had the first of the second two pieces of news yesterday …. LOL

Buyers seem to be returning.

LOL, we haven't even had any IP deal news yet.....

No stock mate!

Nice volume today and shows the interest has returned - those looking to build a stake (I already have mine thank you) just need to be patient and wait for the nervous nellies to sell in to the point of their break even and snap up their shares.

We can expect more news in a few weeks we are told by ME in yesterday RNS and hopefully a deal or two or three! fingers crossed.

GLA NAI DYOR

Can we start pumping at circa 5p level at least please!

Or £3.25mn warrants?

It was THX that fxxxxxx the SP up from 30p, so awaiting a THX 2.0 that actually pays this time that is worth +$100mn!

CLX is the behemoth though of course.

On the cusp of something very special here and now, for a large multi-bag that is here to stay, as opposed to the sad past of promises and failures which ME has put right. When you special out everything in that list, wow ME has made an enormous impact!

What is CLX worth?

What is NEW 201 SPW worth (with 301) ?

The lab, vials, 3000 FDA drugs and contracts?

New evaluations?

401?